HomeDRUG • NASDAQ
Bright Minds Biosciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.58M | -2.70% |
Net income | 49.61K | 102.95% |
Net profit margin | — | — |
Earnings per share | 0.01 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.90M | 756.25% |
Total assets | 58.40M | 747.95% |
Total liabilities | 571.59K | -33.08% |
Total equity | 57.83M | — |
Shares outstanding | 7.04M | — |
Price to book | 3.54 | — |
Return on assets | -12.25% | — |
Return on capital | -12.41% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 49.61K | 102.95% |
Cash from operations | -1.49M | -81.78% |
Cash from investing | — | — |
Cash from financing | 52.04M | 5,826.92% |
Net change in cash | 52.18M | 381,838.17% |
Free cash flow | -912.07K | -356.55% |
Previous close
$29.25
Day range
$28.98 - $31.67
Year range
$0.93 - $79.02
Market cap
310.92M CAD
Avg Volume
39.10K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
About
Founded
2017
Website
